GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ProUroCare Medical Inc (GREY:PUMD) » Definitions » Cyclically Adjusted Price-to-FCF

ProUroCare Medical (ProUroCare Medical) Cyclically Adjusted Price-to-FCF : (As of May. 28, 2024)


View and export this data going back to 2002. Start your Free Trial

What is ProUroCare Medical Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


ProUroCare Medical Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for ProUroCare Medical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProUroCare Medical Cyclically Adjusted Price-to-FCF Chart

ProUroCare Medical Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ProUroCare Medical Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ProUroCare Medical's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, ProUroCare Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProUroCare Medical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ProUroCare Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where ProUroCare Medical's Cyclically Adjusted Price-to-FCF falls into.



ProUroCare Medical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

ProUroCare Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2013 is calculated as:

For example, ProUroCare Medical's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2013 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2013 (Change)*Current CPI (Sep. 2013)
=-0.004/98.7900*98.7900
=-0.004

Current CPI (Sep. 2013) = 98.7900.

ProUroCare Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200312 0.000 77.758 0.000
200403 -0.139 79.066 -0.174
200406 -0.532 80.037 -0.657
200409 -0.370 80.121 -0.456
200412 -0.516 80.290 -0.635
200503 -0.182 81.555 -0.220
200506 -0.072 82.062 -0.087
200509 -0.125 83.876 -0.147
200512 -0.142 83.032 -0.169
200603 -0.858 84.298 -1.006
200606 -0.218 85.606 -0.252
200609 -0.032 85.606 -0.037
200612 -0.060 85.142 -0.070
200703 -0.193 86.640 -0.220
200706 -0.110 87.906 -0.124
200709 -0.097 87.964 -0.109
200712 -0.213 88.616 -0.237
200803 -0.250 90.090 -0.274
200806 -0.184 92.320 -0.197
200809 -0.124 92.307 -0.133
200812 -0.069 88.697 -0.077
200903 -0.198 89.744 -0.218
200906 -0.035 91.003 -0.038
200909 -0.039 91.120 -0.042
200912 -0.078 91.111 -0.085
201003 -0.065 91.821 -0.070
201006 -0.048 91.962 -0.052
201009 -0.029 92.162 -0.031
201012 -0.024 92.474 -0.026
201103 -0.016 94.283 -0.017
201106 -0.020 95.235 -0.021
201109 -0.007 95.727 -0.007
201112 -0.009 95.213 -0.009
201203 -0.003 96.783 -0.003
201206 -0.027 96.819 -0.028
201209 -0.017 97.633 -0.017
201212 -0.016 96.871 -0.016
201303 -0.004 98.209 -0.004
201306 -0.012 98.518 -0.012
201309 -0.004 98.790 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ProUroCare Medical  (GREY:PUMD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


ProUroCare Medical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of ProUroCare Medical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ProUroCare Medical (ProUroCare Medical) Business Description

Traded in Other Exchanges
N/A
Address
6440 Flying Cloud Drive, Suite 101, Eden Prairie, MN, USA, 55344
ProUroCare Medical Inc is engaged in developing products for the detection and characterization of male prostate disease. Its initial product is a prostate mechanical imaging device called the ProUroScan system.

ProUroCare Medical (ProUroCare Medical) Headlines

No Headlines